Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dynamic Pharmaceuticals Invesco ETF (PJP)

Dynamic Pharmaceuticals Invesco ETF (PJP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 367,297,200
  • Shares Outstanding, K 4,790
  • 60-Month Beta 0.86
Trade PJP with:
  • Price/Earnings ttm 13.50
  • Annual Dividend & Yield 0.54
  • Most Recent Dividend 0.131
  • Management Fee 0.56%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 24.20%
  • Historical Volatility 17.78%
  • IV Percentile 99%
  • IV Rank 0.00%
  • IV High 25.29% on 02/26/21
  • IV Low 24.20% on 03/01/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio 0.00
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.53 +0.08%
on 03/03/21
82.02 -7.84%
on 02/10/21
-2.89 (-3.68%)
since 02/03/21
3-Month
67.63 +11.77%
on 12/04/20
82.02 -7.84%
on 02/10/21
+7.90 (+11.67%)
since 12/03/20
52-Week
47.14 +60.35%
on 03/23/20
82.02 -7.84%
on 02/10/21
+16.61 (+28.16%)
since 03/03/20

Most Recent Stories

More News
Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

JNJ : 156.22 (-1.76%)
PFE : 34.39 (+2.63%)
MRK : 73.30 (+0.62%)
LLY : 202.00 (-1.05%)
BMY : 60.75 (-0.85%)
PPH : 67.22 (-0.91%)
PJP : 75.59 (-1.41%)
IHE : 176.15 (-1.54%)
XPH : 52.32 (-2.10%)
FTXH : 25.47 (-1.33%)
ETFs to Watch Ahead of Georgia Senate Runoff

Stocks came crashing on the first day of the New Year in apprehension of the outcome of the Georgia run-off elections.

ICLN : 24.27 (-6.55%)
TAN : 94.50 (-6.44%)
PKB : 45.78 (-0.56%)
IHF : 235.00 (-1.30%)
PJP : 75.59 (-1.41%)
ITOT : 88.81 (-1.40%)
KRE : 66.47 (+0.86%)
IFRA : 32.26 (+0.19%)
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

ALXN : 148.19 (-1.45%)
AZN : 47.16 (-1.19%)
PPH : 67.22 (-0.91%)
BBH : 171.37 (-3.54%)
FBT : 161.76 (-3.36%)
PJP : 75.59 (-1.41%)
PBE : 71.02 (-4.51%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 67.22 (-0.91%)
NVO : 71.46 (-1.68%)
AZN : 47.16 (-1.19%)
BMY : 60.75 (-0.85%)
PJP : 75.59 (-1.41%)
IHE : 176.15 (-1.54%)
ETFs to Shine on Lilly's Coronavirus Antibody Progress

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 67.22 (-0.91%)
PJP : 75.59 (-1.41%)
IHE : 176.15 (-1.54%)
XPH : 52.32 (-2.10%)
3 Reasons to Bet on Healthcare ETFs

The broader medical sector should be in the spotlight now on hopes of a coronavirus vaccine and the likelihood of a divided congress.

AZN : 47.16 (-1.19%)
PFE : 34.39 (+2.63%)
GILD : 62.75 (-0.41%)
MRNA : 131.22 (-10.62%)
LLY : 202.00 (-1.05%)
PPH : 67.22 (-0.91%)
PJP : 75.59 (-1.41%)
XPH : 52.32 (-2.10%)
PSCH : 180.45 (-2.09%)
XHS : 100.76 (-2.04%)
FTXH : 25.47 (-1.33%)
Vaccine Hopes & Divided Government: Sector ETFs to Win

News that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial has instilled more optimism in the markets.

PFE : 34.39 (+2.63%)
JETS : 26.55 (+1.22%)
IHF : 235.00 (-1.30%)
PJP : 75.59 (-1.41%)
RYE : 41.40 (+1.67%)
ROOF : 23.92 (+1.41%)
KRE : 66.47 (+0.86%)
BNTX : 97.25 (-7.36%)
ETF Areas to Win/Lose With Biden on the Verge of Victory

Though the counting process for the U.S. election outcome is still on, the prospect of a Joe Biden presidency marked by a divided Congress is rife.

XLK : 129.42 (-2.52%)
KBE : 51.69 (+0.04%)
TAN : 94.50 (-6.44%)
MNA : 32.54 (-0.73%)
IHF : 235.00 (-1.30%)
PJP : 75.59 (-1.41%)
PPA : 68.88 (-0.03%)
PSP : 14.48 (-0.21%)
FDN : 216.36 (-4.27%)
CLOU : 25.83 (-4.90%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 67.22 (-0.91%)
NVO : 71.46 (-1.68%)
AZN : 47.16 (-1.19%)
BMY : 60.75 (-0.85%)
PJP : 75.59 (-1.41%)
IHE : 176.15 (-1.54%)
Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 52.32 (-2.10%)
RPRX : 43.57 (-7.20%)
HZNP : 91.01 (-3.68%)
PJP : 75.59 (-1.41%)
IHE : 176.15 (-1.54%)
MYOK : 224.91 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Invesco Dynamic Pharmaceuticals ETF is based on the Dynamic Pharmaceutical Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies...

See More

Top 10 Holdings

Name % Holdings
Abbott Laboratories 5.43%
AbbVie Inc 5.41%
GILEAD SCI 5.40%
ELI LILLY 5.40%
Amgen Inc 5.34%
Pfizer Inc 5.34%
Johnson & Johnson 5.26%
MERCK & CO 5.26%
Horizon Pharma Inc 3.21%
Perrigo Co 3.18%

See More

Key Turning Points

3rd Resistance Point 77.19
2nd Resistance Point 76.84
1st Resistance Point 76.22
Last Price 75.59
1st Support Level 75.25
2nd Support Level 74.90
3rd Support Level 74.28

See More

52-Week High 82.02
Last Price 75.59
Fibonacci 61.8% 68.70
Fibonacci 50% 64.58
Fibonacci 38.2% 60.46
52-Week Low 47.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar